{"DataElement":{"publicId":"2676535","version":"1","preferredName":"Non-Hodgkin Lymphoma Transplantation Time Recurrent Disease Chemosensitivity Type","preferredDefinition":"A description of the sensitivity to chemotherapy for the recurrent non-hodgkin lymphoma at the time of transplantation.","longName":"NHL_RLP_CHEMSNS_TYP","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2676528","version":"1","preferredName":"Non-Hodgkin Lymphoma Transplantation Time Recurrent Disease","preferredDefinition":"Distinct from Hodgkin lymphoma both morphologically and biologically, Non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss.  The clinical course varies according to the morphologic type.  NHL is clinically classified as indolent, aggressive, or having a variable clinical course.  NHL can be of B-or T-/NK-cell lineage._The grafting of tissues from one individual to another or place to place within a single individual._The continuum of experience in which events pass from the future through the present to the past._The return of a disease after a period of remission.","longName":"NHL_TRN_TME_RLPS","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2676484","version":"1","preferredName":"Non-Hodgkin's Lymphoma","preferredDefinition":"Distinct from Hodgkin's lymphoma both morphologically and biologically, NHL lymphoma is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss.  The clinical course varies according to the morphologic type.  NHL is clinically classified as indolent, aggressive, or having a variable clinical course.  NHL can be of B-or T-/NK-cell lineage. --2003","longName":"C3211","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Hodgkin Lymphoma","conceptCode":"C3211","definition":"Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"393A575A-007A-282D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-03","modifiedBy":"ONEDATA","dateModified":"2007-09-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2676463","version":"1","preferredName":"Transplantation Time Recurrent Disease","preferredDefinition":"The grafting of tissues from one individual to another or place to place within a single individual.:the continuum of experience in which events pass from the future through the present to the past.:the return of a sign, symptom, or disease after a remission.","longName":"C15342:C25207:C38155","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transplantation","conceptCode":"C15342","definition":"Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Time","conceptCode":"C25207","definition":"The continuum of experience in which events pass from the future through the present to the past.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3938A932-CA86-725A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-03","modifiedBy":"ONEDATA","dateModified":"2007-09-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"394ECF99-BF90-3AC5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-04","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2486888","version":"1","preferredName":"Chemosensitivity Type","preferredDefinition":"Sensitivity of a malignancy to administration of chemotherapy, usually defined as the achievement of a partial response or better._Something distinguishable as an identifiable class based on common qualities.","longName":"CHEM_SENS_TYP","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"9","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"395037C6-23BA-52BE-E044-0003BA3F9857","beginDate":"2007-09-04","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-04","modifiedBy":"ALEYR","dateModified":"2007-09-04","deletedIndicator":"No"},{"value":"Untreated","valueDescription":"Without Therapeutic Procedure","ValueMeaning":{"publicId":"2676532","version":"1","preferredName":"Without Therapeutic Procedure","longName":"2676532","preferredDefinition":"Used to indicate the absence or lack of something or someone. (from Merriam-Webster OnLine): An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"395037C6-23C9-52BE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-04","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"395037C6-23E2-52BE-E044-0003BA3F9857","beginDate":"2007-09-04","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-04","modifiedBy":"ALEYR","dateModified":"2007-09-04","deletedIndicator":"No"},{"value":"Resistant","valueDescription":"Resistance","ValueMeaning":{"publicId":"2674643","version":"1","preferredName":"Resistance","longName":"2674643","preferredDefinition":"Failure of a cancer to shrink after treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Resistance","conceptCode":"C19391","definition":"Failure of a cancer to shrink after treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"384C7304-8808-48E4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-22","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"395037C6-23EE-52BE-E044-0003BA3F9857","beginDate":"2007-09-04","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-04","modifiedBy":"ALEYR","dateModified":"2007-09-04","deletedIndicator":"No"},{"value":"Sensitive","valueDescription":"Sensitivity","ValueMeaning":{"publicId":"2676533","version":"1","preferredName":"Sensitivity","longName":"2676533","preferredDefinition":"A measure of the minimum change in an input signal that an instrument can detect.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sensitivity","conceptCode":"C68816","definition":"A measure of the minimum change in an input signal that an instrument can detect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"395037C6-23FC-52BE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-04","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"395037C6-2415-52BE-E044-0003BA3F9857","beginDate":"2006-06-16","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-04","modifiedBy":"ALEYR","dateModified":"2007-09-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008570","version":"1","preferredName":"Personal attributes","preferredDefinition":"NCI Thesaurus code: CL003786: Personal Attribute\r\n","longName":"PERSONAL_ATTRIBUTES","context":"SPOREs","contextVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"B7FD1513-11B0-2714-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-03","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-03-03","modifiedBy":"SBREXT","dateModified":"2004-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2724589","version":"1","preferredName":"Chemosensitivity Type","preferredDefinition":"Sensitivity of a malignancy to administration of chemotherapy, usually defined as the achievement of a partial response or better.:Type; a subdivision of a particular kind of thing.","longName":"C71488:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemosensitivity","conceptCode":"C71488","definition":"Sensitivity of a malignancy to administration of chemotherapy, usually defined as the achievement of a partial response or better.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4455D875-2DF8-060D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-22","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-01-22","modifiedBy":"ONEDATA","dateModified":"2008-01-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"165D4F55-1DB3-1A89-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"pre_ted_nhl_senstv_chemo","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedClinicalInterpretation:value","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"If there was a relapse of non","type":"Preferred Question Text","description":"If there was a relapse of non-hodgkin lymphoma at the time of transplantation, what was the sensitivity to chemotherapy?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping for CDE:2676535","type":"BRIDG Mapping Path","description":"PerformedObservation [assess sens.] > PerformedClinicalInterpretation.value(ANY=>CD) WHERE PerformedObservation [assess sens.] > DefinedObservation.nameCode = \"assess sensitivity to chemo\" AND PerformedObservation [assess sens.] > Subject > PerformedObservation [assess HL status] >  PerformedDiagnosis.value = \"non-hodgkin lymphoma\" AND PerformedDiagnosis.diseaseStatusCode = \"relapse\" AND PerformedObservation [assess HL status] > DefinedObservation [assess HL status] > DefinedCompositionRelationship > DefinedProcedure [treatment of HL] > DefinedCompositionRelationship > DefinedProcedure [overall HCT process] > DefinedCompositionRelationship > DefinedProcedure [prep reg] > DefinedCompostionRelationship > DefinedObservation [assess sens.]","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3950379A-45CC-5160-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-04","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-04","modifiedBy":"KUMMEROA","dateModified":"2021-06-04","changeDescription":". 2021-6-4 ak System generated def displayed as alt def. 1/8/14mn-added Bridg info.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}